Durham, NC22 Active Studies

Interstitial Cystitis Clinical Trials in Durham, NC

Find 22 actively recruiting interstitial cystitis clinical trials in Durham, NC. Connect with local research sites and explore new treatment options.

22
Active Trials
14
Sponsors
5,899
Enrolling

Recruiting Interstitial Cystitis Studies in Durham

About Interstitial Cystitis Clinical Trials in Durham

Interstitial cystitis/bladder pain syndrome is a chronic condition causing bladder pressure, bladder pain, and sometimes pelvic pain. It primarily affects women and can significantly impact quality of life. Treatment includes dietary changes, bladder instillations, oral medications, and neuromodulation.

There are currently 22 interstitial cystitis clinical trials recruiting participants in Durham, NC. These studies are seeking a combined 5,899 participants. Research is being sponsored by University of Miami, National Alliance for Sickle Cell Centers, Boston Children's Hospital and 11 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Cystitis Clinical Trials in Durham — FAQ

Are there interstitial cystitis clinical trials in Durham?

Yes, there are 22 interstitial cystitis clinical trials currently recruiting in Durham, NC. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Durham?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Durham research site will contact you about next steps.

Are clinical trials in Durham free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Durham studies also compensate for your time and travel.

What interstitial cystitis treatments are being tested?

The 22 active trials in Durham are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial cystitis.

Data updated September 2, 2026 from ClinicalTrials.gov